Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FENST
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,128
Award facts
- Contract value 100% obligated
- $2,127.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,127.93 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on January 5, 2026, with an ultimate completion date of January 6, 2026, represents one of numerous orders issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The PPV-G GEN V contract, valued at $499.999 billion with a completion date of December 31, 2036, is part of a broader $30.3 billion DLA acquisition strategy designed to establish multiple regional prime vendor contractors supplying comprehensive pharmaceutical products to Department of Defense healthcare facilities worldwide.
As an established pharmaceutical supplier to federal military medical operations, DMS Pharmaceutical Group distributes an extensive portfolio including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, specialty pharmaceuticals, and medical consumables. The company has demonstrated consistent performance on numerous DLA delivery orders spanning therapeutic categories ranging from oncology treatments and immunosuppressants to emergency medications and routine pharmaceuticals. This delivery order was issued with no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. The award is funded by the Defense Logistics Agency with no identified subcontractors.
Quick answers
Who was awarded contract SPE2DU26FENST?
SPE2DU26FENST was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DU26FENST worth?
The government has obligated $2,128 on SPE2DU26FENST.
Is contract SPE2DU26FENST an order under another contract?
Yes. SPE2DU26FENST is a delivery order under SPE2DU25D9420, an indefinite delivery contract.
Was contract SPE2DU26FENST competed?
The extent of competition for SPE2DU26FENST was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award